A detailed history of Harvey Investment CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harvey Investment CO LLC holds 4,405 shares of BMY stock, worth $250,204. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,405
Previous 5,005 11.99%
Holding current value
$250,204
Previous $208,000 9.62%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $23,795 - $31,050
-600 Reduced 11.99%
4,405 $228,000
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $51,324 - $60,852
-1,200 Reduced 19.34%
5,005 $254,000
Q4 2018

Jan 31, 2019

BUY
$48.76 - $63.23 $302,555 - $392,342
6,205 New
6,205 $323,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harvey Investment CO LLC Portfolio

Follow Harvey Investment CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Investment CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Investment CO LLC with notifications on news.